Kitago Lab
Clinical Trials

You are here

TRANSPORT2: Transcranial Direct Current Stimulation for Post-stroke Motor Recovery

In-Progress / Currently Recruiting Participants
June 1, 2019
Trial Identifier: 
Published Clinical Trial:
Transport2 Header

What Do We Do?

This research is being done to find out if non-invasive brain stimulation combined with a rehabilitation therapy improves arm weakness that is caused by a stroke. The stimulation is called transcranial direct current stimulation (tDCS), which applies a weak electrical current to stimulate specific areas of the brain. All participants will receive 10 sessions of rehabilitation with the hand that was affected by the stroke while wearing a mitt on the unaffected hand during therapy and at home, a special type of rehabilitation known as constraint-induced movement therapy. Each session of therapy will last about two and a half hours. During the first part of each therapy session, participants will receive tDCS while performing the exercises.


Participants will receive $75/visit. The entire study from start to finish will comprise of at least 15 visits; this includes the initial screening visit in addition to the 10 therapy sessions as well as evaluations conducted before and after the therapy sessions.


Age Range: 
18-80 years old
Inclusion Criteria: 
  • Are 18-80 years old
  • Had a first-time ischemic stroke (caused by a blood clot) that occurred at least 1 month but not more than 6 months ago
  • Experience residual arm or hand weakness

If you are a stroke survivor, or know someone who has had a stroke, but do not qualify for this study, we ask that you still contact us. We offer other programs that you or someone you know may be eligible for.


National Institute of Neurological Disorders and Stroke (NINDS)


Joshua Silverstein, B.S.

Study Locations

Burke Neurological Institute
785 Mamaroneck Avenue
White Plains, CA 10605